PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 268.00
-4.00 (-1.47%)
Apr 29, 2026, 9:36 AM WIB
IDX:DGNS Revenue
In the year 2025, PT Diagnos Laboratorium Utama Tbk had annual revenue of 166.62B IDR with 2.18% growth. PT Diagnos Laboratorium Utama Tbk had revenue of 48.35B in the quarter ending December 31, 2025, with 21.74% growth.
Revenue
166.62B
Revenue Growth
+2.18%
P/S Ratio
2.04
Revenue / Employee
1.50B
Employees
111
Market Cap
340.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 166.62B | 3.55B | 2.18% |
| Dec 31, 2024 | 163.07B | 17.38B | 11.93% |
| Dec 31, 2023 | 145.70B | -47.19B | -24.47% |
| Dec 31, 2022 | 192.89B | -109.30B | -36.17% |
| Dec 31, 2021 | 302.18B | 119.01B | 64.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Millennium Pharmacon International Tbk | 4.11T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Phapros Tbk | 961.30B |
| PT Ikapharmindo Putramas Tbk | 377.10B |
| PT Royal Prima Tbk | 338.91B |